Nordea Investment Management Ab Incyte Corp Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Incyte Corp stock. As of the latest transaction made, Nordea Investment Management Ab holds 12,585 shares of INCY stock, worth $875,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,585

Previous 82,671 84.78%

Holding current value

$875,035

Previous $5.01 Million 83.42%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$57.33 - $68.61 $4.02 Million - $4.81 Million	-70,086 Reduced 84.78%	12,585 $831,000
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $51,282 - $63,877	-1,002 Reduced 1.2%	82,671 $5.01 Million
Q1 2024 May 02, 2024	SELL	$56.55 - $66.59 $42,864 - $50,475	-758 Reduced 0.9%	83,673 $4.77 Million
Q4 2023 Jan 10, 2024	SELL	$52.16 - $64.19 $55,498 - $68,298	-1,064 Reduced 1.24%	84,431 $5.3 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $4.27 Million - $4.88 Million	73,944 Added 640.15%	85,495 $4.94 Million
Q2 2023 Jul 07, 2023	SELL	$60.95 - $75.51 $49,979 - $61,918	-820 Reduced 6.63%	11,551 $719,000
Q1 2023 Apr 19, 2023	BUY	$70.23 - $86.01 $80,764 - $98,911	1,150 Added 10.25%	12,371 $894,000
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $78,936 - $98,829	-1,175 Reduced 9.48%	11,221 $901,000
Q3 2022 Oct 19, 2022	BUY	$66.18 - $82.86 $105,027 - $131,498	1,587 Added 14.68%	12,396 $838,000
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $128,521 - $161,535	1,942 Added 21.9%	10,809 $811,000
Q3 2021 Nov 01, 2021	SELL	$68.67 - $84.02 $608,896 - $745,005	-8,867 Reduced 50.0%	8,867 $616,000
Q3 2021 Nov 01, 2021	BUY	$68.67 - $84.02 $608,896 - $745,005	8,867 Added 100.0%	17,734 $0
Q2 2021 Jul 16, 2021	SELL	$79.87 - $87.53 $1.2 Million - $1.31 Million	-15,023 Reduced 62.88%	8,867 $746,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $13,987 - $18,492	-184 Reduced 0.76%	23,890 $1.96 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $212,023 - $256,560	2,626 Added 12.24%	24,074 $2.09 Million
Q3 2020 Nov 09, 2020	SELL	$85.07 - $109.69 $2.43 Million - $3.13 Million	-28,562 Reduced 57.11%	21,448 $1.93 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $2.28 Million - $3.35 Million	30,760 Added 159.79%	50,010 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $4,928 - $6,705	-78 Reduced 0.4%	19,250 $1.38 Million
Q4 2019 Feb 11, 2020	BUY	$73.04 - $95.72 $808,698 - $1.06 Million	11,072 Added 134.11%	19,328 $1.69 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $147,407 - $177,843	-2,005 Reduced 19.54%	8,256 $702,000
Q1 2019 May 20, 2019	BUY	$63.56 - $88.17 $4,639 - $6,436	73 Added 0.72%	10,261 $882,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $99,232 - $119,287	1,607 Added 18.73%	10,188 $703,000
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $39,121 - $47,561	471 Added 5.81%	8,581 $715,000
Q4 2017 Feb 12, 2018	SELL	$93.56 - $116.6 $39,950 - $49,788	-427 Reduced 5.0%	8,110 $768,000
Q3 2017 Nov 09, 2017	BUY	$109.15 - $138.27 $931,813 - $1.18 Million	8,537	8,537 $997,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Incyte Corp Transaction History